Insulin pump market growth is propelled by advancements in technology, rising global diabetes prevalence, and increased demand for precision diabetes management.New Delhi, Feb. 06, 2025 (GLOBE ...

Insulin pump therapy, also known as continuous subcutaneous insulin infusion (CSII), is an important and evolving form of insulin delivery, which is mainly used for people with type 1 diabetes.

Hybrid closed loop technology was associated with superior efficacy and safety outcomes relative to standard insulin therapy in T1D.

Insulin solutions must be placed in an infusion pump and piggybacked into the lower distal port of a maintenance i.v. line with a rate of at least 20 mL/hr. (Use 0.9% sodium chloride injection if ...

including inhaled or injectable insulin if they do not use an insulin infusion pump. A diabetes screening usually involves a fasting blood glucose test or a post-glucose challenge test.

The Global Implantable Drug Delivery Devices Market was valued at USD 26.7 Bn in 2023. It is expected to reach USD 57.1 Bn by 2033, with a CAGR of 8.1% ...

Beta Bionics’ IPO marks one of the largest public offerings for an Orange County-based company in over three years, second ...

Activist investor Starboard Value is urging Becton Dickinson to sell its life sciences division, citing potential value gains. Analysts estimate a spin-off could boost the company's worth by up to 30% ...

The so-called 'hybrid closed-loop' system comprises a blood glucose sensor, the MiniMed 670G insulin pump and an infusion patch. Type 1 diabetes patients using the device will no longer have to ...

an insulin pump strapped to the body, and an infusion patch with a catheter that delivers insulin from the pump. Although the system does automatically adjust insulin delivery based on blood ...